drugset / Trial / NCT03143972

Pharmacodynamic Interaction of REMI and DMED

NCT03143972

Phase 4 Completed 30 enrolled University Medical Center Groningen
Non-randomizedCrossoverOpen-labelSupportive care

Summary

The objective is to map the pharmacokinetic / pharmacodynamic interaction between dexmedetomidine and remifentanil by observing changes in anesthetic depth. These changes will be related to drug concentrations using pharmacokinetic/pharmacodynamic (PKPD) modeling.

Timeline

Start
2017-06-28
Primary completion
2018-02-23
Completion
2018-02-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified Other
Subject Remifentanil Small molecule Other

Indications

No indication recorded.